Home >> Investor Relations
Investor Relations          
 

Investor Relations

   Stock Information
   Ownership Structure
   Financial Reports
   Regulatory Filings
   Analysts
Investor Relations
 
Home
 

 Recent Financial Reports
1 August 2010
Board of Directors Report - 1st Quarter 2010
Auditor's Report - 1st Quarter 2010
 
21 March 2010
2009 Annual Financial Statements
 
26 November 2009
Shelf Prospectus
 
View all financial reports ►

 

          

 Recent Investor Presentations
13 June 2010
BiondVax - Corporate Presentation, June 2010
 
11 May 2010
BiondVax - Investor Presentation, May 2010 (Hebrew)
 
 

 

 Recent News
17 August 2010
BiondVax Announces Receipt of Ethics ('Helsinki') Committee Approvals for the Initiation of first Phase II Clinical Trial for Universal Influenza Vaccine
 
28 July 2010
Frost & Sullivan Awards '2010 European Influenza Vaccines Technology Innovation Award' to BiondVax Pharmaceuticals for Universal Influenza Vaccine
 
14 June 2010
BiondVax to Present Universal Flu Vaccine Data at Two Upcoming BioPharma Industry Conferences
 
9 June 2010
BiondVax Awarded $1 Million Universal Flu Vaccine Grant from Israeli Office of the Chief Scientist
 
28 April 2010
Second successful Phase I/II Clinical Trial for BiondVax’s Universal Flu Vaccine
 
View all news stories ►

 

    

 Recent & Upcoming Events
Vaccine Forum Barcelona 2010
21-23 June 2010, Barcelona, Spain
 
ILSI BioMed 2010 Conference
15 June 2010, Tel Aviv, Israel
 
Annual General Shareholders' Meeting
16 May 2010, Nes-Ziona, Israel
 
TASE Healthcare Conference
11 May 2010, Tel Aviv, Israel
 
Bio International Convention 2010
4-6 May 2010, Chicago, USA